Sg3 Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $338,500 - $383,750	-25,000 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$13.17 - $16.4 $329,250 - $409,999	25,000 New	25,000 $341,000
Q2 2019 Aug 09, 2019	SELL	$16.58 - $20.49 $1.85 Million - $2.29 Million	-111,550 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $1.86 Million - $2.4 Million	111,550 New	111,550 $2.27 Million

336

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.6B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.